day 1 agenda

6th International Conference on
COGNITIVE AND BEHAVIORAL NEUROSCIENCES (ICBN-2026)
September 07-08 in Paris, France
Meeting Hall - Paris 3
Registrations open 08:30-08:50
Moderator:
Sonya Miller, United Kingdom
Welcome Remarks by Moderator 09:00-09:10
 Day 1- September 07, 2026
Keynote Sessions
Yovav Eshet,
Zefat Academic College, Israel
09:00-09:30 Keynote Talk: Enhancing Academic Integrity through Creative Thinking in AI-Driven Higher Education
Robert Fettiplace,
University of Wisconsin-Madison, USA
09:30-10:00 Keynote Talk: Hair Cell Apoptosis and Deafness
Carol Manning
University of Virginia, USA
10:00-10:30 Keynote Talk: Individualized Coordination and Empowerment for Care Partners of Persons with Dementia ICECaP
Sid O’Bryant,
University of North Texas Health Science Center, USA
10:30-11:00 Keynote Talk: Alzheimer’s Disease Biomarkers Among Diverse Populations – Updates and Future Directions
Group Photo & Refreshment Break (11:00-11:20)
Technical Session-I
Cognitive, Affective and Behavioral Neuroscience
&
Alzheimer's & Dementia Research and Therapy
Session Chairs
Daniel Stein, Israel & Youssef Sari, USA
Ilan Laufer,
Ariel University,
Israel
11:20-11:40 Title: Attachment anxiety and selective frontal-theta amplification during punished early responses in an interval-reproduction task   
Jiancheng Hou,
Fujian Normal University, China
11:40-12:00 Title: Differences in structural brain morphometry between musicians and non-musicians     
Avi Avital,
University of Haifa, Israel
12:00-12:20 Title: Attention Regulation Among Sleep-Deprived Air Force Pilots   
Lei Han,
BGI Research, China
12:20-12:40 Title: Single-cell spatial transcriptomic atlas of the whole mouse brain   
Youssef Sari,
University of Toledo, USA
12:40-13:00 Title: Novel synthetic GLT-1 modulators as potential therapeutic compounds for the treatment of Drugs of Abuse   
Simon Reay Atkinson,
University of Sydney,
Australia
13:00-13:20 Title: Can humanity keep its jitter? – existential human knowledge vitality verse interstitial machine knowledge perfection?   
Lunch Break @ Restaurant (13:20-14:00)
Technical Session-II

Neurocognitive Disorders / Psychiatric Disorders
Session Chair 
Ilan Laufer, Israel
Veit Stuphorn,
Johns Hopkins University, USA
14:00-14:20 Title: The role of attention in multi-attribute decision making   
Hongxing Wang,
Zhongda Hospital Southeast University, China
14:20-14:40 Title: Development and validation of a nomogram for predicting outcomes in patients with prolonged disorders of consciousness
Qing Zhang,
Shanghai Jiao Tong University School of Medicine, China
14:40-15:00 Title: Ethical governance of clinical research on the brain–computer interface for mental disorders: a modified Delphi study
Daniel Stein,
Tel Aviv University, Israel
15:00-15:20 Title: LEGO® therapy in anorexia nervosa
Yuliy Fradkin,
Rutgers University,
USA
15:20-15:40 Title: A Randomized Sham-Controlled Clinical Trial Evaluating the Safety and Efficacy of Transcranial Photobiomodulation to Improve Symptoms of Autism Spectrum Disorder and Brain Electrophysiology in Children Aged 2–6 Years
Thomas Küchelmann,
Bielefeld University, Germany
15:40-16:00 Title: Expertise-dependent mental representation in chess: evaluation and comparisons based on structural dimensional analysis-motoric
Daphna Joel,
Tel Aviv University, Israel
16:00-16:20 Title: Beyond the binary: New ways of studying the relations between sex and the brain
Sonya Miller
TauRx Therapeutics, United Kingdom
16:20-16:40 Title: Alzheimer’s Disease Pathophysiology and Research Targets
Garrison W Cottrell
University of California, USA
16:40-17:00 Title: An anatomical explanation for the inverted face effect
Martin Göpfert
University of Göttingen, Germany
17:00-17:20 Title: Identification of a gating spring that initiates mechanosensation
Alexandre Dumais
University of Montreal, Canada
17:20-17:40 Title: Virtual reality-based Avatar Therapy for treatment-resistant major depressive disorder: Results of a pilot clinical trial
Refreshment Break (17:40-18:00)
Day-1 Concludes


Virtual Program- Followed by Paris Time(CEST)
 Day 2- September 08, 2026
James McLure,
Deakin University, Australia
08:40-09:00 A lived experience transformation of mental illness to mental health: Inspiring a movement of hope
Mikhail Kiselev,
Chuvash State University, Russia
09:00-09:20 Purely Spiking Reinforcement Learning – from Model-Free to Model-Based
Robert John Aumann,
Hebrew University of Jerusalem, Israel
09:20-09:50 Keynote Talk: Why Consciousness?
Lusine Brsikian,
Russia Center of  Neurology and Neurosciences, Russia
09:50-10:10 Clinical and neurophysiological characteristics of sleep in Alzheimer’s disease
Slot Available 10:10-10:30 Slot Available
Hamama Liat,
Tel Aviv University, Israel
10:30-10:50 Well-Being among Parents of Youth with Multiple Sclerosis: A preliminary Longitudinal Study
Elisabetta Palagi,
University of Pisa, Italy
10:50-11:10 Moving bodies, social bonds: The evolutionary roots of social connection
Rakhee Kundu,
Amity University, India
11:10-11:30 ResNeXt convolutional forward harmonic network for autism spectrum   
Elizabeth Simes,
University College London, United Kingdom
11:30-11:50 Findings from the MOAM trial: mentalization-based treatment for antisocial personality disorder—clinical outcomes, mechanisms, and peer research involvement
Slot Available 11:50-12:10 Slot Available
Torsten Baldeweg,
University College London, United Kingdom
12:10-12:30  Long-term developmental trajectories in children with focal epilepsy: cognitive and neuroimaging evidence
Elena Mirela Samfira,
University of Life Sciences, Romania
12:30-12:50 Teachers’ pupil control ideology: correlations with self-acceptance, perfectionism, and irrational beliefs
Ève Poudrier,
University of British Columbia, Canada
12:50-13:10 Modeling polyrhythmic experience in a corpus of polyphonic music from Europe and North-America, 1877–1969
Dean Zeldich,
Thomas Jefferson University Hospital, USA
13:10-13:30 Apolipoprotein E4 and Its Impact on Neurodegeneration and Disease Progression in
Multiple Sclerosis
Philip Spiller,
United States Food and Drug Administration, USA
13:30-14:00 Plenary Talk: Fish consumption advice is depriving children of neurolipids and other nutrients essential to brain and eye development
Rodica Elena Petrea,
California Touro University, USA
14:00-14:20 Transthyretin cardiac (TTR) amyloidosis and vascular dementia
Pierfilippo De Sanctis,
Albert Einstein College of Medicine, USA
14:20-14:40 Neural Signatures of Complex Daily Activities in Older Adults at Risk for Cognitive Decline
Kymberly Young,
University of Pittsburgh, USA
14:40-15:00 Real-Time fMRI amygdala neurofeedback for major depressive disorder: Progress and Challenges   
Susan A. J. Birch,
The University of British Columbia, Canada
15:00-15:20 Targeting cognitive biases to improve social cognition and social emotional health   
Samah Ibrahim,
McGill University, Canada
15:20-15:40 Administering Electroconvulsive Therapy to Critically Ill Individuals: Risks, Monitoring, and Benefits   
Dana C Hilt,
Actinogen Medical, USA
15:40-16:00 The role of cortisol in CNS disease –11β-HSD1 inhibition as a potential new therapeutic for neuropsychiatric diseases   
Scott Matthews ,
Yale University School of Medicine, USA
16:00-16:20 Virtual Reality and Psychedelics: Toward New Models of Consciousness and Novel Treatments for Alcohol Use Disorder   
Ana I. Schwartz,
The University of Texas at El Paso, USA
16:20-16:40 The impact of cross-language co-activation of cognates on bilingual performance on the reading span task   
Bradley K. Taylor,
University of Pittsburgh, USA
16:40-17:00 Parabrachial neuropeptide Y Y1 receptor-expressing neurons govern the need-state control of neuropathic pain   
Thomas F. Collura,
BrainMaster Technologies, Inc, USA
17:00-17:20 Emerging standards for clinical quantitative electroencephalography: The IQCB guideline   
Utkarsh Shukla,
Western University, Canada
17:20-17:40 Development and validation of Hindi-English bilingual irony stimuli for psycholinguistic and cognitive neuroscience research   
Day-2 Concludes

Download